Triumph Capital Management Sana Biotechnology, Inc. Transaction History
Triumph Capital Management
- $300 Million
- Q2 2025
A detailed history of Triumph Capital Management transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Triumph Capital Management holds 14,675 shares of SANA stock, worth $45,492. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,675
Previous 21,675
32.3%
Holding current value
$45,492
Previous $36,000
11.11%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SANA
# of Institutions
170Shares Held
115MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$77.5 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$34.2 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$31.6 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$31.5 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$24.4 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $590M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...